Home › Pulmonary Fibrosis › Minnesota
Pulmonary Fibrosis clinical trials in Minnesota
3 studies for Pulmonary Fibrosis are looking for participants at sites in Minnesota.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Minnesota, Minneapolis
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- University of Minnesota, Minneapolis
- Mayo Clinic in Rochester, Rochester
Recruiting
Ages 18 and older · All sexes · Updated Mar 20, 2026 · NCT06751069Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jan 21, 2026 · NCT05120934From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.